Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 153 - Utilization of Historical Data for Confirmatory Trials
Type: Topic Contributed
Date/Time: Tuesday, August 4, 2020 : 10:00 AM to 11:50 AM
Sponsor: Biopharmaceutical Section
Abstract #312948
Title: Improving Clinical Trial Efficiency Using Natural History Study Data and Innovative Trial Design
Author(s): Barbara Wendelberger* and Melanie Quintana and Scott Berry
Companies: Berry Consultants, LLC and Berry Consultants and Berry Consultants
Keywords: Natural history ; Disease progression; Bayesian; Innovative ; Clinical trials; Design

Natural history studies (NHS) are an important resource that should be utilized during clinical trial design. NHS data provides information on the expectation and variability of potential clinical endpoints, biomarkers, and other predictors, which help explain disease progression. Modeling disease progression provides a realistic estimate of disease state, which can be leveraged along with simulation, to guide clinical trial design. This innovative approach to trial design supports a Bayesian statistical framework aimed at providing patient-centered care, while efficiently and ethically identifying effective treatments. This talk focuses on a real case example that highlights the benefits of using NHS data to design a well-powered trial in a progressive disease. Specifically, we will consider how to characterize the primary endpoint, model disease progression, augment placebo data, simulate virtual trials, and leverage innovative analysis methods to create an effective and clinically interpretable trial design.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2020 program